TLD(Tenofovir,lamivudine & dolutegravir is recommended by the World Health Organization for first-line treatment of HIV. It can also be used in second-line treatment of HIV.
The following are the benefits of TLD:
- to improve the lives of people living with HIV.
- to provide rapid viral suppression
- has high genetic barrier to resistance
- has fewer side effects
- has smaller tablet – easy to take